Magnesium orotate
Chemical compound
- A12CC09 (WHO)
- magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate
- 34717-03-8 Y
- 3036905
- 2300801
- GI96W46M5A
- DTXSID20905129
- Interactive image
- [Mg+2].O=C([O-])\C1=C\C(=O)NC(=O)N1.[O-]C(=O)\C1=C\C(=O)NC(=O)N1
InChI
- InChI=1S/2C5H4N2O4.Mg/c2*8-3-1-2(4(9)10)6-5(11)7-3;/h2*1H,(H,9,10)(H2,6,7,8,11);/q;;+2/p-2
- Key:QWLHYYKDLOVBNV-UHFFFAOYSA-L
Magnesium orotate, the magnesium salt of orotic acid, is a mineral supplement. It can be used in treating extracellular magnesium deficiency, as well as in mitigating magnesium depletion that inhibits the binding of adenosine triphosphate via orotic acid, which provides binding sites.[1]
References
- ^ Classen HG (2004). "Magnesium orotate--experimental and clinical evidence". Romanian Journal of Internal Medicine. 42 (3): 491–501. PMID 16366126.
- v
- t
- e
Mineral supplements (A12)
Calcium# |
|
---|---|
Magnesium | |
Phosphorus | |
Potassium | |
Sodium | |
Sulfur |
|
Copper | |
---|---|
Iodine | |
Iron |
|
Selenium | |
Zinc |
|
Chromium |
|
---|---|
Fluorine | |
Lithium | |
Vanadium |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e